Zobrazeno 1 - 10
of 17
pro vyhledávání: '"W. Kosel"'
Autor:
Michael J. Mugavero, Bradley W Kosel, Sudershan Singh, Heidi M. Crane, Paul K. Crane, James H. Willig, Mari M. Kitahata, Michael S. Saag, Robert H. Knopp, Robert D. Harrington
Publikováno v:
Clinical Infectious Diseases. 52:387-395
Alabama Background. Dyslipidemia is common and is often treated with 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins). Little is known about the comparative effectiveness of statins among human immunodeficiency virus (HI
Publikováno v:
Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films. 14:727-732
In situ studies of plasma‐treated poly(ethylene terephthalate) [PET] followed by metallization suggested a viable process for treating and silver coating PET support to manufacture suitable silver‐coated base material. Following this work and som
Publikováno v:
Journal of Adhesion Science and Technology. 7:885-896
A time-resolved salt bath technique was employed for assessing the adhesion of silver coatings on poly(ethylene terephthalate) (PET) web. Furthermore, a basis for quantitative comparisons of adhesion was developed. The salt bath test was applied to s
Autor:
Joseph A. Church, Lewis B. Sheiner, Bradley W. Kosel, Francesca T. Aweeka, Dolors Soy, Paul Palumbo, Coleen K. Cunningham
Publikováno v:
Clinical pharmacology and therapeutics. 74(6)
Objective Our objective was to describe the population pharmacokinetics and pharmacodynamics of enfuvirtide acting on viral ribonucleic acid in children with human immunodeficiency virus 1. Methods A 1-compartment population pharmacokinetic model wit
Autor:
Roslyn J. Leiser, Donald I. Abrams, Judith A. Aberg, Joseph M. McCune, Francesca T. Aweeka, Peter Bacchetti, Joan F. Hilton, Steven G. Deeks, Morris Schambelan, Thomas F. Mitchell, Tarek Elbeik, Barry M. Bredt, Bradley W. Kosel, Neal L. Benowitz, Kathleen Mulligan, Starley B. Shade
Publikováno v:
Annals of internal medicine. 139(4)
Cannabinoid use could potentially alter HIV RNA levels by two mechanisms: immune modulation or cannabinoid-protease inhibitor interactions (because both share cytochrome P-450 metabolic pathways).To determine the short-term effects of smoked marijuan
Publikováno v:
AIDS (London, England). 17(8)
BACKGROUND Protease inhibitor (PI)-based combination antiretroviral therapy is often indicated for treatment of maternal HIV disease, but little is known about PI pharmacokinetics during pregnancy. Increased cytochrome P450 activity may affect the di
Autor:
John G. Gerber, Terrence F. Blaschke, Yoninah Segal, Carl J. Fichtenbaum, Susan L. Rosenkranz, Francesca T. Aweeka, Judith A. Aberg, Beverly Alston, Bradley W. Kosel, Fang Fang
Publikováno v:
AIDS (London, England). 16(4)
Objective: Lipid lowering therapy is used increasingly in persons with HIV infection in the absence of safety data or information on drug interactions with antiretroviral agents. The primary objectives of this study were to examine the effects of rit
Autor:
Donald I. Abrams, Bradley W. Kosel, Neal L. Benowitz, Starley B. Shade, Patricia Lizak, Francesca T. Aweeka, Joan F. Hilton
Publikováno v:
AIDS (London, England). 16(4)
Background and objectives The use of cannabinoids for appetite stimulation and the management of wasting and antiretroviral side-effects has become a common practice in the care of HIV-infected individuals. We present pharmacokinetic data from a rand
Autor:
B W, Kosel, F, Aweeka
Publikováno v:
AIDS clinical review.
Publikováno v:
AIDS. 22:164-165